GlassScriptPhysician profile
Bryan K Berger
NPI 1861692329
$1,287.41
in general payments reported to CMS, 2019-2025
9 companies · $39.61 in 2025
The $39.61 reported for 2025 was less than what a typical Epilepsy provider received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $195 · 2021: $164 · 2022: $301 · 2023: $132 · 2024: $283 · 2025: $39.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.80 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $796.66 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $164.66 | 2021-2025 | |
| Eisai INC. | $115.57 | 2020 | |
| Ucb, INC. | $89.32 | 2022 | |
| Supernus Pharmaceuticals, INC. | $59.00 | 2020 | |
| Sk Life Science, INC. | $24.58 | 2021 | |
| Allergan, INC. | $20.90 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.